{"transactions":[{"id":709205,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":30368,"kind":"person","name":"Skaff Michael C","position":1,"cik":"0002074003","reported_name":"Skaff Michael C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Purchase Warrant","published_at":"2026-07-15T20:23:47.000Z","date":"2026-06-30","kind":"purchase","planned":false,"acquired":true,"shares":2749330,"price":0.582,"value":1600110.06,"ownership":{"direct":false,"nature":"By V-Co Investors 4 LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Michael C. Skaff serves as Managing Director of SP Manager LLC, the Manager of V-Co Investors 4 LLC. Michael C. Skaff and SP Manager LLC disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":2749330,"derivative":{"exercise_price":0.456,"exercise_date":"2026-06-30","expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":2749330},"source":{"system":"sec-edgar","filing":"0001193125-26-304815","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2074003/000119312526304815/ownership.xml","form_type":"4"}},{"id":709204,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":30368,"kind":"person","name":"Skaff Michael C","position":1,"cik":"0002074003","reported_name":"Skaff Michael C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2026-07-15T20:23:47.000Z","date":"2026-06-30","kind":"purchase","planned":false,"acquired":true,"shares":1890164,"price":0.582,"value":1100075.448,"ownership":{"direct":false,"nature":"By V-Co Investors 4 LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On June 30, 2026, V-Co Investors 4 LLC converted a bridge promissory note in the amount of $1,000,000 entered into between the reporting person and the Issuer into shares of the Issuer's Series A Convertible Preferred Stock, based on $0.456 per share plus $0.125 per share in accordance with the Nasdaq minimum price rules."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The convertible preferred stock is convertible at any time, at the holder's election, subject to a beneficial ownership limitation, and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The convertible preferred stock is convertible at any time, at the holder's election, subject to a beneficial ownership limitation, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Michael C. Skaff serves as Managing Director of SP Manager LLC, the Manager of V-Co Investors 4 LLC. Michael C. Skaff and SP Manager LLC disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":2749330,"derivative":{"exercise_price":0.456,"underlying":"Common Stock","underlying_shares":1890164},"source":{"system":"sec-edgar","filing":"0001193125-26-304815","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2074003/000119312526304815/ownership.xml","form_type":"4"}},{"id":709203,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":30368,"kind":"person","name":"Skaff Michael C","position":1,"cik":"0002074003","reported_name":"Skaff Michael C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2026-07-15T20:23:47.000Z","date":"2026-06-30","kind":"purchase","planned":false,"acquired":true,"shares":859166,"price":0.582,"value":500034.612,"ownership":{"direct":false,"nature":"By V-Co Investors 4 LLC"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The convertible preferred stock is convertible at any time, at the holder's election, subject to a beneficial ownership limitation, and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The convertible preferred stock is convertible at any time, at the holder's election, subject to a beneficial ownership limitation, and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Michael C. Skaff serves as Managing Director of SP Manager LLC, the Manager of V-Co Investors 4 LLC. Michael C. Skaff and SP Manager LLC disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":859166,"derivative":{"exercise_price":0.456,"underlying":"Common Stock","underlying_shares":859166},"source":{"system":"sec-edgar","filing":"0001193125-26-304815","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2074003/000119312526304815/ownership.xml","form_type":"4"}},{"id":820501,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":30368,"kind":"person","name":"Skaff Michael C","position":1,"cik":"0002074003","reported_name":"Skaff Michael C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":52837,"kind":"organization","name":"V-Co Investors 3 LLC","position":2,"cik":"0002114460","reported_name":"V-Co Investors 3 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Common Stock Warrant","published_at":"2026-04-02T23:34:11.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":1783582,"price":1.34,"value":2389999.88,"ownership":{"direct":false,"nature":"By V-Co Investors 3 LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Michael C. Skaff serves as Managing Director of SP Manager LLC, the Manager of V-Co Investors 3 LLC. Michael C. Skaff and SP Manager LLC disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":1783582,"derivative":{"exercise_price":1.09,"exercise_date":"2026-03-31","expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":1783582},"source":{"system":"sec-edgar","filing":"0002074003-26-000008","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2074003/000207400326000008/ownership.xml","form_type":"4"}},{"id":820500,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":30368,"kind":"person","name":"Skaff Michael C","position":1,"cik":"0002074003","reported_name":"Skaff Michael C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":52837,"kind":"organization","name":"V-Co Investors 3 LLC","position":2,"cik":"0002114460","reported_name":"V-Co Investors 3 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Common Stock Warrant","published_at":"2026-04-02T23:34:11.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":1783582,"price":1.34,"value":2389999.88,"ownership":{"direct":false,"nature":"By V-CO Investors 3 LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Michael C. Skaff serves as Managing Director of SP Manager LLC, the Manager of V-Co Investors 3 LLC. Michael C. Skaff and SP Manager LLC disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":1783582,"derivative":{"exercise_price":1.09,"exercise_date":"2026-03-31","expiration_date":"2028-03-31","underlying":"Common Stock","underlying_shares":1783582},"source":{"system":"sec-edgar","filing":"0002074003-26-000008","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2074003/000207400326000008/ownership.xml","form_type":"4"}},{"id":820499,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":30368,"kind":"person","name":"Skaff Michael C","position":1,"cik":"0002074003","reported_name":"Skaff Michael C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":52837,"kind":"organization","name":"V-Co Investors 3 LLC","position":2,"cik":"0002114460","reported_name":"V-Co Investors 3 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrant","published_at":"2026-04-02T23:34:11.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":429957,"price":1.34,"value":576142.38,"ownership":{"direct":false,"nature":"By V-CO Investors 3 LLC"},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Pre-Funded Warrant has a term ending on the complete exercise of the Pre-Funded Warrant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Michael C. Skaff serves as Managing Director of SP Manager LLC, the Manager of V-Co Investors 3 LLC. Michael C. Skaff and SP Manager LLC disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":429957,"derivative":{"exercise_price":0.0001,"exercise_date":"2026-03-31","underlying":"Common Stock","underlying_shares":429957},"source":{"system":"sec-edgar","filing":"0002074003-26-000008","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2074003/000207400326000008/ownership.xml","form_type":"4"}},{"id":820498,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":30368,"kind":"person","name":"Skaff Michael C","position":1,"cik":"0002074003","reported_name":"Skaff Michael C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":52837,"kind":"organization","name":"V-Co Investors 3 LLC","position":2,"cik":"0002114460","reported_name":"V-Co Investors 3 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T23:34:11.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":308848,"price":1.34,"value":413856.32,"ownership":{"direct":false,"nature":"By V-CO Investors 3 LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Michael C. Skaff serves as Managing Director of SP Manager LLC, the Manager of V-Co Investors 3 LLC. Michael C. Skaff and SP Manager LLC disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":1353625,"source":{"system":"sec-edgar","filing":"0002074003-26-000008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2074003/000207400326000008/ownership.xml","form_type":"4"}},{"id":820497,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":30368,"kind":"person","name":"Skaff Michael C","position":1,"cik":"0002074003","reported_name":"Skaff Michael C","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":52837,"kind":"organization","name":"V-Co Investors 3 LLC","position":2,"cik":"0002114460","reported_name":"V-Co Investors 3 LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T23:34:11.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":1044777,"price":1.34,"value":1400001.18,"ownership":{"direct":false,"nature":"By V-CO Investors 3 LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 31, 2026, V-Co Investors 3, LLC  converted a bridge promissory note in the amount of $1,400,000 entered into between the reporting person and the Issuer into shares of the Issuer's common stock, based on $1.09 per share of Common Stock plus $0.25 per share in accordance with the Nasdaq minimum price rules."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Michael C. Skaff serves as Managing Director of SP Manager LLC, the Manager of V-Co Investors 3 LLC. Michael C. Skaff and SP Manager LLC disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":1044777,"source":{"system":"sec-edgar","filing":"0002074003-26-000008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2074003/000207400326000008/ownership.xml","form_type":"4"}}]}